Cargando…

Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection

Background: Lassa virus (LASV) can cause severe acute systemic infection in humans. No approved antiviral drugs or vaccines are currently available. Antibody-based therapeutics are considered a promising treatment strategy in the management of LASV disease. Methods: We used chimeric Ifnar(−/−) C57BL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oestereich, Lisa, Müller-Kräuter, Helena, Pallasch, Elisa, Strecker, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384048/ https://www.ncbi.nlm.nih.gov/pubmed/37515124 http://dx.doi.org/10.3390/v15071436

Ejemplares similares

Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever
por: Oestereich, Lisa, et al.
Publicado: (2016)

The Road towards Polyclonal Anti-SARS-CoV-2 Immunoglobulins (Hyperimmune Serum) for Passive Immunization in COVID-19
por: Focosi, Daniele, et al.
Publicado: (2021)

Passive Monoclonal and Polyclonal Antibody Therapies
por: Pelletier, J. Peter R., et al.
Publicado: (2020)

Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
por: de Alwis, Ruklanthi, et al.
Publicado: (2020)

Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies
por: Perrett, Hailee R., et al.
Publicado: (2023)

Chimeric Mice with Competent Hematopoietic Immunity Reproduce Key Features of Severe Lassa Fever
por: Oestereich, Lisa, et al.
Publicado: (2016)

Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins Against SARS-CoV-2
por: Burnouf, Thierry, et al.
Publicado: (2022)

Lack of Protection following Passive Transfer of Polyclonal Highly Functional Low-Dose Non-Neutralizing Antibodies
por: Dugast, Anne-Sophie, et al.
Publicado: (2014)

Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection
por: Brouwer, Philip J.M., et al.
Publicado: (2022)

Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19
por: Alape-Girón, Alberto, et al.
Publicado: (2021)

Human Polyclonal Antibodies Prevent Lethal Zika Virus Infection in Mice
por: Branche, Emilie, et al.
Publicado: (2019)

Structure of the Lassa virus glycan shield provides a model for immunological resistance
por: Watanabe, Yasunori, et al.
Publicado: (2018)

Phylogeography of Lassa Virus in Nigeria
por: Ehichioya, Deborah U., et al.
Publicado: (2019)

Animal Models of Lassa Fever
por: Sattler, Rachel A., et al.
Publicado: (2020)

Prevention and Treatment of Influenza with Hyperimmune Bovine Colostrum Antibody
por: Ng, Wy Ching, et al.
Publicado: (2010)

Resistant prolactinoma: Is it monoclonal or polyclonal?
por: Kumar, K. V. S. Hari, et al.
Publicado: (2013)

ANTI-DNA ANTIBODIES IN HYPERIMMUNIZED RABBITS
por: Christian, Charles L., et al.
Publicado: (1965)

Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity
por: Müller, Helena, et al.
Publicado: (2020)

Production of anti‐SARS‐CoV‐2 hyperimmune globulin from convalescent plasma
por: Vandeberg, Peter, et al.
Publicado: (2021)

Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues
por: Port, Julia R., et al.
Publicado: (2020)

Determining Ribavirin’s mechanism of action against Lassa virus infection
por: Carrillo-Bustamante, Paola, et al.
Publicado: (2017)

Imported Case of Lassa Fever in Sweden With Encephalopathy and Sensorineural Hearing Deficit
por: Grahn, Anna, et al.
Publicado: (2016)

A Sporadic and Lethal Lassa Fever Case in Forest Guinea, 2019
por: Magassouba, N’Faly, et al.
Publicado: (2020)

Development of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection
por: Dowall, Stuart David, et al.
Publicado: (2016)

Transplacental transfer of Lassa IgG antibodies in pregnant women in Southern Nigeria: A prospective hospital-based cohort study
por: Kayem, Nzelle Delphine, et al.
Publicado: (2023)

Hyperimmune Globulin for Severely Immunocompromised Patients Hospitalized With Coronavirus Disease 2019: A Randomized, Controlled Trial
por: Huygens, Sammy, et al.
Publicado: (2022)

Lassa antiviral LHF-535 protects guinea pigs from lethal challenge
por: Cashman, Kathleen A., et al.
Publicado: (2022)

Colostrum Antibodies, Egg Antibodies and Monoclonal Antibodies Providing Passive Immunity for Animals
por: DuBourdieu, Dan
Publicado: (2019)

Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID mice
por: Hohenadl, Christine, et al.
Publicado: (2014)

The role of myristoylation in the membrane association of the Lassa virus matrix protein Z
por: Strecker, Thomas, et al.
Publicado: (2006)

Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses
por: Bounds, Callie E., et al.
Publicado: (2015)

Lassa fever in Benin: description of the 2014 and 2016 epidemics and genetic characterization of a new Lassa virus
por: Yadouleton, Anges, et al.
Publicado: (2020)

Polyclonal alpaca antibodies protect against hantavirus pulmonary syndrome in a lethal Syrian hamster model
por: Sroga, Patrycja, et al.
Publicado: (2021)

Detection of Lassa Virus-Reactive IgG Antibodies in Wild Rodents: Validation of a Capture Enzyme-Linked Immunological Assay
por: Soubrier, Hugo, et al.
Publicado: (2022)

Hyperimmune Globulins for the Management of Infectious Diseases
por: Pati, Ilaria, et al.
Publicado: (2023)

Protective Efficacy and Mechanism of Passive Immunization with Polyclonal Antibodies in a Sepsis Model of Staphylococcus aureus Infection
por: Zhang, Jinyong, et al.
Publicado: (2015)

A recombinant vesicular stomatitis-based Lassa fever vaccine elicits rapid and long-term protection from lethal Lassa virus infection in guinea pigs
por: Stein, Derek R., et al.
Publicado: (2019)

Specific Detection of Acanthamoeba species using Polyclonal Peptide Antibody Targeting the Periplasmic Binding Protein of A. castellanii
por: Kim, Min-Jeong, et al.
Publicado: (2022)

Failure of Passive Immunity Transfer Is Not a Risk Factor for Omphalitis in Beef Calves
por: Perrot, Florent, et al.
Publicado: (2023)

Viral RNA and infectious virus in mucosal specimens from guinea pigs modelling early phases of lethal and non-lethal Lassa fever
por: Welch, Stephen R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ig5j1ll2malpj9peiv9hbt5o1n